Statistics for Tight control for Crohn-s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

Total visits

views
Tight control for Crohn-s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial 0

Total visits per month

views
October 2023 0
November 2023 0
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0

File Visits

views
Tight control for Crohn's disease.pdf 7